Premium
Nurix Therapeutics Inc (NRIX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| BlackRock, Inc. | Institution | 8 925 621 | 8,63% | US$ 172,26M | 2026-03-31 |
| Redmile Group, LLC | Institution | 7 031 908 | 6,80% | US$ 135,72M | 2026-04-20 |
| Vestal Point Capital, LP | Institution | 6 500 000 | 6,29% | US$ 125,45M | 2026-03-31 |
| Deep Track Capital, LP | Institution | 6 345 244 | 6,14% | US$ 122,46M | 2026-03-31 |
| FMR LLC | Institution | 5 540 664 | 5,36% | US$ 106,93M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 5 500 000 | 5,32% | US$ 106,15M | 2025-05-15 |
| State Street Global Advisors, Inc. | Institution | 5 141 195 | 4,97% | US$ 99,23M | 2026-03-31 |
| Morgan Stanley | Institution | 4 884 703 | 4,72% | US$ 94,27M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 4 658 556 | 4,51% | US$ 89,91M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 4 427 112 | 4,28% | US$ 85,44M | 2026-03-31 |
| General Atlantic Service Company, L.P. | Institution | 4 101 865 | 3,97% | US$ 79,17M | 2026-03-31 |
| Commodore Capital Master LP | Institution | 3 850 000 | 3,72% | US$ 74,31M | 2025-02-07 |
| Perceptive Advisors LLC | Institution | 3 710 877 | 3,59% | US$ 71,62M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 3 290 233 | 3,18% | US$ 63,50M | 2026-03-31 |
| Pictet Asset Management Limited | Institution | 2 726 138 | 2,64% | US$ 52,61M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 2 520 229 | 2,44% | US$ 48,64M | 2026-03-31 |
| Rubric Capital Management LP | Institution | 2 473 885 | 2,39% | US$ 47,75M | 2026-03-31 |
| Deutsche Asset & Wealth Management | Institution | 2 295 024 | 2,22% | US$ 44,29M | 2026-03-31 |
| Commodore Capital LP | Institution | 2 275 000 | 2,20% | US$ 43,91M | 2026-03-31 |
| Braidwell LP | Institution | 1 750 766 | 1,69% | US$ 33,79M | 2026-03-31 |
| Trails Edge Capital Partners, LP | Institution | 1 743 220 | 1,69% | US$ 33,64M | 2026-03-31 |
| ARK Investment Management LLC | Institution | 1 721 135 | 1,66% | US$ 33,22M | 2026-03-31 |
| Longaeva Partners L.P. | Institution | 1 490 202 | 1,44% | US$ 28,76M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 343 700 | 1,30% | US$ 25,93M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 1 297 893 | 1,26% | US$ 25,05M | 2026-03-31 |
| Kynam Capital Management, LP | Institution | 1 194 757 | 1,16% | US$ 23,06M | 2026-03-31 |
| Amova Asset Management Co., Ltd. | Institution | 1 181 146 | 1,14% | US$ 22,80M | 2026-03-31 |
| UBS Asset Management AG | Institution | 1 133 712 | 1,10% | US$ 21,88M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 1 102 266 | 1,07% | US$ 21,27M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 967 620 | 0,94% | US$ 18,68M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 941 035 | 0,91% | US$ 18,16M | 2026-03-31 |
| Soleus Capital Management, L.P. | Institution | 938 163 | 0,91% | US$ 18,11M | 2026-03-31 |
| Woodline Partners LP | Institution | 925 444 | 0,89% | US$ 17,86M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 924 039 | 0,89% | US$ 17,83M | 2026-03-31 |
| Capital Research and Management Company | Institution | 893 327 | 0,86% | US$ 17,24M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 854 466 | 0,83% | US$ 16,49M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 780 696 | 0,75% | US$ 15,07M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
